Lineage Cell Therapeutics, Inc.

LCTX·AMEX·$1.29Share Price as of 11/2·$322MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report06/12/26 8-KCurrent report05/12/26 8-KCurrent report03/11/26 8-KCurrent report03/05/26

Prospectuses and Registrations

424B5Prospectus supplement03/11/26 S-3Shelf registration03/11/26 424B3Prospectus11/12/25 S-8Registration of securities for employees08/15/25 424B5Prospectus supplement11/21/24

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEFA14AAdditional proxy materials06/11/25 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25

Ownership

SC 13GBeneficial ownership07/29/26 Form 4Insider transaction07/02/26 Form 4Insider transaction07/02/26 Form 4Insider transaction07/02/26 Form 4Insider transaction07/02/26

Other

ARSAnnual report to shareholders04/29/26 EFFECTRequest for effectiveness03/23/26 CORRESPCorrespondence with the SEC03/19/26 UPLOADLetter from the SEC03/16/26 ARSAnnual report to shareholders04/29/25